Full-Time

Total Rewards Partner – Sr Manager

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Mississauga, ON, Canada

Employees are required to work in the office 3 days a week.

Category
Human Resources
People & HR
Required Skills
Data Analysis
Requirements
  • Education to Degree level with 8+ years of experience in Total Rewards, including Compensation, Benefits, Retirement Savings, and Wellness programs and policies, including experience with DC Pension Plans
  • Knowledge of Retirement Savings governance and regulations
  • Significant experience with Workday functionality
Responsibilities
  • Maintain Thrive Wellness programs and compile annual utilization assessments.
  • Manage annual benefits re-enrollment with vendors, ensuring smooth implementation and facilitation of information sessions.
  • Execute Retirement Savings initiatives and employee communications, including training and campaigns.
  • Oversee semi-monthly Retirement Savings contribution files, resolving discrepancies as needed, and manage Sun Life claims and premiums invoicing.
  • Facilitate the Rewarding Performance Development cycle, involving analysis, reporting, training and communication.
  • Manage the annual updates of the Total Reward Statement, to ensure meaningful and robust information is shared.
  • Implement Pay Transparency to ensure legislative compliance and provide employee/manager education and awareness.
  • Support annual Market Reference Point process, compensation and leveling processes, as well as Pay Equity legislative reviews.
  • Serve as the primary contact for employee inquiries regarding benefits, retirement savings, wellness, and manage the Leave of Absence process, including Workday record management.
  • Participate in reviews and projects to leverage Workday system data, where needed.
  • Assist in developing and updating Total Reward policies and processes, ensuring legislative compliance is maintained.
Desired Qualifications
  • SME Post Graduate Qualification (i.e. CEB) - is desirable/ an asset.

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery could enhance AstraZeneca's R&D efficiency.
  • Real-world evidence supports AstraZeneca's efforts in demonstrating drug efficacy and safety.
  • Personalized medicine aligns with AstraZeneca's focus on precision medicine.

What critics are saying

  • AstraZeneca faces a class-action lawsuit over alleged Soliris monopoly practices.
  • AI tools for breast cancer screening may face challenges due to minority underrepresentation.
  • Investment in Dunkirk may be at risk due to potential regulatory changes.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast